ASTH (NASDAQ: ASTH) reported Q3 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $478.7 million versus the consensus estimate of $462.4 million.

GUIDANCE:

ASTH sees FY2024 EPS of $1.06-$1.19, versus the consensus of $1.84. ASTH sees FY2024 revenue of $1.95-2.03 billion, versus the consensus of $1.83 billion.

For earnings history and earnings-related data on ASTH (ASTH) click here.